Search
for
Sort by
Research 871–900 of 1000+
- Intracrine and Myotrophic Roles of 5α-Reductase and Androgens
- Minoxidil increases 17β-hydroxysteroid dehydrogenase and 5α-reductase activity of cultured human dermal papilla cells from balding scalp
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Age-related changes in brain and pituitary 5α-reductase with finasteride (Proscar) treatment
- Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment
- Evaluation of New Pregnane Derivatives as 5.ALPHA.-Reductase Inhibitor.
- Oral Testosterone in Oil: Pharmacokinetic Effects of 5 Reduction by Finasteride or Dutasteride and Food Intake in Men
- Effect of a novel steroid (PM-9) on the inhibition of 5α-reductase present in Penicillium crustosum broths
- Progesterone-induced stimulation of mammary tumorigenesis is due to the progesterone metabolite, 5α-dihydroprogesterone (5αP) and can be suppressed by the 5α-reductase inhibitor, finasteride
- Simultaneous pharmacokinetic and pharmacodynamic analysis of 5α-reductase inhibitors and androgens by liquid chromatography tandem mass spectrometry
- Avicequinone C Isolated from Avicennia marina Exhibits 5α-Reductase-Type 1 Inhibitory Activity Using an Androgenic Alopecia Relevant Cell-Based Assay System
- Molecular interactions of progesterone derivatives with 5α-reductase types 1 and 2 and androgen receptors
- A high-performance liquid chromatography–tandem mass spectrometry assay of the androgenic neurosteroid 3α-androstanediol (5α-androstane-3α,17β-diol) in plasma
- Diffuse hypertrichosis during treatment with 5% topical minoxidil
- Clinical and hormonal effects of the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism
- Safety aspects of androgen treatment with 5α-dihydrotestosterone
- Pustular allergic contact dermatitis from topical minoxidil 5%
- Treatment of trichostasis spinulosa with 0.5-millisecond pulsed 755-nm alexandrite laser
- In Vivo Investigation in Pigs of Intestinal Absorption, Hepatobiliary Disposition, and Metabolism of the 5α-Reductase Inhibitor Finasteride and the Effects of Coadministered Ketoconazole
- Is the metabolism of testosterone to 5α-dihydrotestosterone required for androgen action in the skin?
- Efficacy and safety of oral minoxidil 5 mg daily during 24-week treatment in male androgenetic alopecia
- Invalidation of a commercially available human 5α-dihydrotestosterone immunoassay
- Plasma androsterone/epiandrosterone sulfates as markers of 5α-reductase activity: Effect of finasteride in normal men
- Treatment of androgenetic alopecia with a 7.5% herbal preparation
- Greater conversion of testosterone to 5α-dihydrotestosterone, reflecting increased peripheral 5α-reductase activity in nude mice treated with high doses of cyclosporine A
- Pathologic Quiz Case: An Anterior Neck Mass in a 5-Month-Old Female Infant
- Comparative GC-MS Based In vitro Assays of 5α-Reductase Activity Using Rat Liver S9 Fraction
- 5α-Metabolism in Finasteride-Treated Subjects and Male Pseudohermaphrodites with Inherited 5α-Reductase Deficiency
- Efficacy of Cetirizine 1% Versus Minoxidil 5% Topical Solution in the Treatment of Male Alopecia: A Randomized, Single-blind Controlled Study
- Frontal edema due to topical application of %5 minoxidil solution following mesotherapy injections